Peralta, Merlifer O.
HRN: 06-03-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2026
CEFTRIAXONE 1G (VIAL)
04/27/2026
05/04/2026
IVTT
2g
OD
CAP
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: